#LyX 2.2 created this file. For more info see http://www.lyx.org/
\lyxformat 508
\begin_document
\begin_header
\save_transient_properties true
\origin unavailable
\textclass article
\begin_preamble
\usepackage[font=small,labelfont=bf]{caption}

\newcommand*\name[1]{#1}                                                                                                                                                                                                                       
\newcommand*\abbrv[1]{#1}                                                                                                                                                                                                                      
\newcommand*\rpkg[1]{\textit{#1}}                                                                                                                                                                                                              
\newcommand*\file[1]{\textit{#1}}                                                                                                                                                                                                              
\newcommand{\code}[1]{\texttt{#1}}                                                                                                                                                                                                             
                                                                                                                                                                                                                                               
\newcommand*\protein[1]{#1}                                                                                                                                                                                                                    
\newcommand*\gene[1]{\textit{#1}}                                                                                                                                                                                                              
\end_preamble
\use_default_options true
\maintain_unincluded_children false
\language british
\language_package default
\inputencoding auto
\fontencoding global
\font_roman "default" "default"
\font_sans "default" "default"
\font_typewriter "default" "default"
\font_math "auto" "auto"
\font_default_family default
\use_non_tex_fonts false
\font_sc false
\font_osf false
\font_sf_scale 100 100
\font_tt_scale 100 100
\graphics default
\default_output_format default
\output_sync 0
\bibtex_command default
\index_command default
\paperfontsize default
\spacing single
\use_hyperref false
\papersize default
\use_geometry false
\use_package amsmath 1
\use_package amssymb 1
\use_package cancel 1
\use_package esint 1
\use_package mathdots 1
\use_package mathtools 1
\use_package mhchem 1
\use_package stackrel 1
\use_package stmaryrd 1
\use_package undertilde 1
\cite_engine natbib
\cite_engine_type numerical
\biblio_style plain
\use_bibtopic false
\use_indices false
\paperorientation portrait
\suppress_date false
\justification true
\use_refstyle 1
\index Index
\shortcut idx
\color #008000
\end_index
\secnumdepth 3
\tocdepth 3
\paragraph_separation indent
\paragraph_indentation default
\quotes_language english
\papercolumns 1
\papersides 1
\paperpagestyle default
\tracking_changes false
\output_changes false
\html_math_output 0
\html_css_as_file 0
\html_be_strict false
\end_header

\begin_body

\begin_layout Part
Building an Improved Model of Perturbation-Response Genes
\end_layout

\begin_layout Standard
There are numerous examples of using Gene Set Enrichment Analysis (GSEA)
 for a set of signalling molecules in order to infer signalling activity.
 Most of them, however, use the expression of those proteins directly as
 a proxy for their activity.
 My hypothesis is that using this footprint of signalling activity is a
 better proxy than assuming that it is proportional to the expression of
 the proteins involved in the signal transduction pathway, which assumes
 the latter accurately represents not only the protein levels but also their
 activity.
 To my knowledge, the only similar efforts are the SPEED database 
\begin_inset CommandInset citation
LatexCommand citep
key "Parikh2010-uj"

\end_inset

 and two studies MCF10A breast signatures 
\begin_inset CommandInset citation
LatexCommand citep
key "Bild2005-tk,Bild2006-vt,Gatza2010-fq,Gatza2011-wd,Gatza2014-as"

\end_inset

.
\end_layout

\begin_layout Standard
Whereas the former used a smaller but still significant set of publicly
 available experiments, the only analysis they did using their signatures
 was to compute the overlap between genes present in their signatures and
 Gene Ontology categories, and genes between their pathways.
\end_layout

\begin_layout Standard
In the latter article the authors experimentally derived pathway-response
 signatures for a single condition (MCF10A cell line, one perturbation/time
 point per experiment).
 Without claiming a direct connection, one of the involved authors later
 had his medical license revoked and multiple articles retracted because
 of irreproducibility of results, as investigated by 
\begin_inset CommandInset citation
LatexCommand cite
key "Baggerly2009-xc"

\end_inset

.
\end_layout

\begin_layout Standard
\begin_inset Float figure
wide false
sideways false
status open

\begin_layout Plain Layout
\align center
\begin_inset Graphics
	filename figures/3.0_method-comparison.pdf
	width 50col%

\end_inset


\end_layout

\begin_layout Plain Layout
\begin_inset Caption Standard

\begin_layout Plain Layout
\begin_inset Argument 1
status collapsed

\begin_layout Plain Layout
Reasoning about pathway activation
\end_layout

\end_inset

Reasoning about pathway activation.
 Most pathway approaches make use of either the set (top panel) or graph
 (middle panel) of signalling molecules to make statements about a possible
 activation, while our approach considered the genes affected by perturbing
 them.
\begin_inset CommandInset label
LatexCommand label
name "fig:Schema-of-different"

\end_inset


\end_layout

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Standard
A later generation of signatures 
\begin_inset CommandInset citation
LatexCommand citep
key "Gatza2010-fq"

\end_inset

 still had this author involved, but the signatures themselves seem to be
 well documented and the raw data was deposited in a public microarray repositor
y.
 Finally, in 2014 the main author 
\begin_inset CommandInset citation
LatexCommand citep
key "Gatza2014-as"

\end_inset

 linked the inferred pathway activity to drug response in a handful of breast
 cancer cell lines.
 The MCF10A cell line itself is non-cancerous, so it will represent the
 behaviour of cells without cancer-causing molecular alterations.
 While the data in general seems to be of high quality, I am not confident
 to make any statements about the genes responsive in this cell line can
 be extrapolated to other tissues, especially because it has previously
 been shown that signatures generated in a certain lab can correlate more
 with the lab they were produced in than the biological condition 
\begin_inset CommandInset citation
LatexCommand citep
key "Chibon2013-rl"

\end_inset

, which I can not control for if there is only one lab producing them.
\end_layout

\begin_layout Standard
\begin_inset Float figure
wide false
sideways false
status open

\begin_layout Plain Layout
\align center
\begin_inset Graphics
	filename figures/3.0_workflow.pdf
	width 50col%

\end_inset


\end_layout

\begin_layout Plain Layout
\begin_inset Caption Standard

\begin_layout Plain Layout
\begin_inset Argument 1
status collapsed

\begin_layout Plain Layout
Workflow of data curation and model building
\end_layout

\end_inset

Workflow of data curation and model building.
 (1) Finding and curation of 208 publicly available experiment series in
 the ArrayExpress database, (2) Extracting 556 perturbation experiments
 from series' raw data, (3) Performing QC metrics and discarding failures,
 (4) Computing z-scores per experiment, (5) Using a multiple linear regression
 to fit genes responsive to all pathways simultaneously obtaining the z-coeffici
ents matrix, (6) Assigning pathway scores using the coefficients matrix
 and basal expression data.
\begin_inset CommandInset label
LatexCommand label
name "fig:Workflow-of-obtaining"

\end_inset


\end_layout

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Standard
So far, it is unknown how well it is possible to derive consensus signatures
 that provide meaningful estimates of pathway activity across different
 conditions.
 Only SPEED computed them, and the authors did not do a detailed investigation
 of either this, or any large-scale functional association with the pathway
 scores they obtained.
 It also relies on a framework that applies multiple arbitrary cutoffs in
 order to obtain signature sets, even though a simple linear model would
 abrogate the requirement for such cutoffs, while being able to take into
 account both up- and downregulated genes.
\end_layout

\begin_layout Standard
\begin_inset VSpace defskip
\end_inset


\end_layout

\begin_layout Standard
The chapter represents the model building stage of improved pathway signatures.
 All analyses, plots, and written text in this thesis I produced myself,
 while incorporating comments from the coauthors:
\end_layout

\begin_layout Standard
\begin_inset VSpace defskip
\end_inset


\end_layout

\begin_layout Standard

\series bold
Schubert M
\series default
, Klinger B, Klünemann M, Garnett MJ, Blüthgen N, Saez-Rodriguez J.
 
\begin_inset Quotes eld
\end_inset


\shape italic
Perturbation-response genes reveal signaling footprints in cancer gene expressio
n
\shape default
.
\begin_inset Quotes erd
\end_inset

 
\series bold
bioRxiv
\series default
 065672 (2016).
 doi:10.1101/065672
\end_layout

\begin_layout Section
Curating and assembling a database of publicly available perturbation experiment
s
\end_layout

\begin_layout Subsection
Defining scope and format
\begin_inset CommandInset label
LatexCommand label
name "subsec:Defining-Relevant-Pathways"

\end_inset


\end_layout

\begin_layout Standard
Because the experiments in the SPEED database were curated in a first iteration
 in 2009 and other pathways were added in 2012, it is quite likely that
 there are many more relevant experiments that were deposited in ArrayExpress
 or GEO after the data was curated.
 Also, previous efforts made no distinction based on the availability of
 raw data or how many arrays were indeed available in a given contrast.
 For the latter, I set the requirement to have at least two arrays in the
 control condition to be able to obtain an estimate of the variability of
 the expressed genes without a pathway perturbation, and one perturbed array
 to compare to the controls.
 I kept the requirement of the original SPEED for the perturbation to last
 24 hours or less in order to focus the analysis on primary pathway responses
 and not long-term rewiring.
\end_layout

\begin_layout Standard
I decided on focussing on the pathway set of the original SPEED publication,
 with the following modifications:
\end_layout

\begin_layout Itemize
Focus on EGFR-related signatures instead of MAPK_PI3K, which could be either
 any of EGFR, MAPK, or PI3K where in the latter two the respective other
 was inhibited
\end_layout

\begin_layout Itemize
MAPK inhibition should be interpreted as inhibition of MAPK, not activation
 of PI3K (which may happen and we do indeed see this in a couple of cases,
 but this is not generally true)
\end_layout

\begin_layout Itemize
Remove TLR, instead use TNFa and NFkB
\end_layout

\begin_layout Standard
Taking into account these modifications, the final pathway sets I re-curated
 were: EGFR, H2O2, JAK-STAT, MAPK, NFkB, p53, PI3K, Trail, VEGF, and TGFb.
\end_layout

\begin_layout Standard
Instead of creating an 
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
abbrv{SQLite}
\end_layout

\end_inset

 database (original 
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
abbrv{SPEED}
\end_layout

\end_inset

) or flat text files with semi-defined fields (additional pathways for the
 original platform), I used the markup language 
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
abbrv{YAML}
\end_layout

\end_inset


\begin_inset Foot
status open

\begin_layout Plain Layout
short for Yet Another Markup Language
\end_layout

\end_inset

 
\begin_inset CommandInset citation
LatexCommand citep
key "Ben-Kiki2005-jo"

\end_inset

 to create index files for all the curated experiments.
 This has the advantage over a simple tabular format in that it supports
 structured data, including field names and comments.
 It has the advantage over XML that it is easily machine- and human-readable.
 It can hence easily be reused by other projects for which a curation of
 perturbation-response experiments on the resolution of pathways is of interest.
 An overview of the format structure is shown in table 
\begin_inset CommandInset ref
LatexCommand ref
reference "tab:yaml-format"

\end_inset

.
\end_layout

\begin_layout Standard
\begin_inset Float table
wide false
sideways false
status open

\begin_layout Plain Layout
\begin_inset Caption Standard

\begin_layout Plain Layout
\begin_inset Argument 1
status collapsed

\begin_layout Plain Layout
Structured data in the YAML file format
\end_layout

\end_inset

Structured data in the YAML file format that I used from experiment curation
 for different pathway perturbation experiments in ArrayExpress
\begin_inset CommandInset label
LatexCommand label
name "tab:yaml-format"

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Plain Layout
\align center
\begin_inset Tabular
<lyxtabular version="3" rows="13" columns="2">
<features tabularvalignment="middle">
<column alignment="center" valignment="top">
<column alignment="center" valignment="top">
<row>
<cell alignment="center" valignment="top" topline="true" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Identifier
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" topline="true" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Description
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
\begin_inset Formula $---$
\end_inset


\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
marker for the beginning of a record
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
id
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
the experiment identifier; consists of 
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
accession
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
the experiment accession in ArrayExpress, e.g.
 E-GEOD-15986
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
platform
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
the microarray platform
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
pathway
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
the pathway identifier
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
cells
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
a description of the cells used in the experiment
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
treatment
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
a description of what the cell were treated with
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
effect
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
if the effect was 
\begin_inset Quotes eld
\end_inset

activating
\begin_inset Quotes erd
\end_inset

 or 
\begin_inset Quotes eld
\end_inset

inhibiting
\begin_inset Quotes erd
\end_inset


\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
hours
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
how many hours the perturbation lasted
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
control
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
a list of array identifiers used for the basal condition
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
perturbed
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
a list of array identifiers used for the perturbed condition
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
...
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
marker for the end of file
\end_layout

\end_inset
</cell>
</row>
</lyxtabular>

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Subsection
Finding suitable Experiments
\begin_inset CommandInset label
LatexCommand label
name "subsec:Finding-suitable-Experiments"

\end_inset


\end_layout

\begin_layout Standard
I used the following searches on the ArrayExpress database to find experiments:
\begin_inset Note Note
status open

\begin_layout Plain Layout
would be good to have citations for every compound here
\end_layout

\end_inset


\end_layout

\begin_layout Itemize
EGFR: (egf* OR "growth factor" OR TGF*alpha OR epiregulin OR heregulin OR
 neuregulin OR epigen OR betacellulin OR amphiregulin OR iressa OR gefitinib
 OR cetuximab OR erlotinib OR lapatinib OR AG1478 OR trastuzumab OR herceptin)
 organism:sapiens samplecount:[4 TO 10000] raw:true exptype:"Transcription
 profiling"
\end_layout

\begin_layout Itemize
H2O2: (h2o2 OR *peroxide) organism:sapiens samplecount:[4 TO 10000] raw:true
 exptype:"Transcription profiling"
\end_layout

\begin_layout Itemize
Hypoxia: (hypoxia* OR HIF1 OR HIF-1) organism:sapiens samplecount:[4 TO
 10000] raw:true exptype:"Transcription profiling"
\end_layout

\begin_layout Itemize
JAK-STAT: (ifn* OR interferon OR JAK OR STAT OR prolaktin OR EPO OR IL-2
 OR IL2 OR IL-3 OR IL3 OR IL-6 OR IL6 OR IL-10 OR IL10 OR IL-13 OR IL13)
 organism:sapiens samplecount:[4 TO 10000] raw:true exptype:"Transcription
 profiling"
\end_layout

\begin_layout Itemize
MAPK: (b-raf OR braf OR raf* OR mek* OR erk* OR PD*0325901 OR CI*1040 OR
 PLX* OR U0126 OR AZD6244 OR GSK1120212 OR *metinib OR PD*325901) organism:sapie
ns samplecount:[4 TO 10000] raw:true exptype:"Transcription profiling"
\end_layout

\begin_layout Itemize
NFkB: (LPS OR sa:lps OR tlr OR sa:lipopolysaccharide OR pam3c* OR zymosan
 OR parthenolide OR sa:11-7082 OR CAY10512 OR sa:*salicyl*) organism:sapiens
 samplecount:[4 TO 10000] raw:true exptype:"Transcription profiling"
\end_layout

\begin_layout Itemize
p53: (sa:*p53 OR sa:mdm2 OR sa:nutlin* OR sa:*radiation OR sa:*radiated
 OR sa:"dna damage" OR sa:ddr OR sa:*rubicin OR sa:*platin OR sa:docetaxel
 OR sa:gamma) organism:sapiens samplecount:[4 TO 10000] raw:true exptype:"Transc
ription profiling"
\end_layout

\begin_layout Itemize
PI3K: (SF1126 OR LY294002 OR TGR*1202 OR SAR2454* OR GSK1059615 OR 80*6946
 OR Perifosine OR Idelalisib OR PI3K OR PIK3* OR PTEN OR BEZ235 OR RP6530
 OR GDC*941 OR INK1117 ) organism:sapiens samplecount:[4 TO 10000] raw:true
 exptype:"Transcription profiling"
\end_layout

\begin_layout Itemize
TNFa: (tnf* OR "necrosis factor") organism:sapiens samplecount:[4 TO 10000]
 raw:true exptype:"Transcription profiling"
\end_layout

\begin_layout Itemize
Trail: (rtrail OR trail* OR fas OR fasl) organism:sapiens samplecount:[4
 TO 10000] raw:true exptype:"Transcription profiling" array:(A-AFFY-33 OR
 A-AFFY-44 OR A-AFFY-37 OR A-AFFY-141)
\end_layout

\begin_layout Itemize
Trail (alternative): (Genasense OR ABT-737 OR ABT-199 OR obatoclax OR GX15-070
 OR casp8 OR caspase) organism:sapiens samplecount:[4 TO 10000] raw:true
 exptype:"Transcription profiling"
\end_layout

\begin_layout Itemize
VEGF: (VEGF* OR sunitinib OR nexavar OR sutent OR pazopanib OR everolimus
 OR afinitor OR votrient OR Bevacizumab OR sorafenib OR itraconazole OR
 PDGF* OR PGF OR FIGF OR Withaferin) organism:sapiens samplecount:[4 TO
 10000] raw:true exptype:"Transcription profiling"
\end_layout

\begin_layout Itemize
TGFb: (tgf OR "tgf-*" OR "bmp*" OR "SMAD*" "transforming growth factor"
 OR "A 83-01" OR "A-83-01" OR "A83-01" OR "D 4476" OR "D4476" OR "D-4476"
 OR "GW 788388" OR "GW788388" OR "GW-788388" OR "LY 364947" OR "LY-364947"
 OR "LY364947" OR "R 268712" OR "R-268712" OR "R268712" OR RepSox OR "SB
 431542" OR "SB-431542" OR "SB431542" OR "SB 505124" OR "SB-505124" OR "SB505124
" OR "SB 525334" OR "SB-525334" OR "SB525334" OR "SD 208" OR "SD208" OR
 "SD-208") organism:sapiens samplecount:[4 TO 10000] raw:true exptype:"Transcrip
tion profiling"
\end_layout

\begin_layout Standard
\begin_inset Float figure
wide false
sideways false
status open

\begin_layout Plain Layout
\align center
\begin_inset Graphics
	filename figures/dataset_size-1.pdf
	lyxscale 50
	width 80col%

\end_inset


\end_layout

\begin_layout Plain Layout
\begin_inset Caption Standard

\begin_layout Plain Layout
\begin_inset Argument 1
status collapsed

\begin_layout Plain Layout
Comparison of dataset size between SPEED, Gatza (2009), and Pathway-responsive
 genes (PRGs)
\end_layout

\end_inset

Comparison of dataset size between SPEED, Gatza (2009), and my Pathway-responsiv
e genes (PRGs).
 
\begin_inset CommandInset citation
LatexCommand citep
key "Gatza2010-fq"

\end_inset

 derived 18 pathway signatures using only the MCF-10A cell line (thus also
 18 experiments), and a total of 287 arrays.
 In 2014, they included additional signatures from other sources to a total
 of 53, but some are redundant, others not pathways, and all still limited
 to breast cancer 
\begin_inset CommandInset citation
LatexCommand citep
key "Gatza2014-as"

\end_inset

.
 SPEED
\begin_inset CommandInset citation
LatexCommand citep
key "Parikh2010-uj"

\end_inset

 assembled consensus signatures for for 11 pathways using 69 GEO submissions,
 215 different conditions and 572 arrays.
 My data set consists of 11 pathways, 217 GEO submissions, 568 different
 experiments and a total of 2687 arrays.
 This means I use more evidence per pathway and cover a broader set of experimen
tal conditions, but also reflects the imposed limitation of only considering
 experiments if there are at least two unperturbed arrays available in order
 to estimate the basal variability.
 In addition, all my expression values are derived from raw data and not
 preprocessed data that I can not reproduce.
\begin_inset CommandInset label
LatexCommand label
name "fig:Size-of-the"

\end_inset


\end_layout

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Standard
Those searches yielded between 30 and 650 results in the database, the majority
 of which had nothing to do with the perturbation I was looking for but
 the search term was rather mentioned in the experiment description.
 I read the description, sample attributes, metadata files, and if required
 the associated article to fill in the required information about each experimen
t (listed in table 
\begin_inset CommandInset ref
LatexCommand ref
reference "tab:yaml-format"

\end_inset

).
\end_layout

\begin_layout Standard
I found a total of 208 submissions encompassing 11 pathways, 572 experiments,
 and a total of 2687 arrays.
 This is the same number of pathways in the SPEED platform 
\begin_inset CommandInset citation
LatexCommand citep
key "Parikh2010-uj"

\end_inset

, but about three times as many experiments and more than four times as
 many microarrays than were used to derived their signatures.
 Because the collection of 
\begin_inset CommandInset citation
LatexCommand citep
key "Gatza2010-fq"

\end_inset

 is breast cancer only and only consists of a single experiment per signature,
 my number of pathway signatures is smaller but the number of overall experiment
al data much bigger (for a comparison, see figure 
\begin_inset CommandInset ref
LatexCommand ref
reference "fig:Size-of-the"

\end_inset

).
\end_layout

\begin_layout Standard
I designed a pipeline to parse the experiment index, and download and process
 the corresponding experimental data as described in section 
\begin_inset CommandInset ref
LatexCommand ref
reference "subsec:From-Experiments-to"

\end_inset

.
 At the time, the release of the 
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
rpkg{ArrayExpress}
\end_layout

\end_inset

 R package was unable to process most of the experiments although the raw
 data as well as experiment description was available.
 In the spirit of increased reusability, I aimed at fixing the package instead
 of just writing my own processing routines, and the new version is available
 on BioConductor
\begin_inset Foot
status open

\begin_layout Plain Layout
\begin_inset CommandInset href
LatexCommand href
target "http://bioconductor.org/packages/release/bioc/html/ArrayExpress.html"

\end_inset


\end_layout

\end_inset

.
\end_layout

\begin_layout Subsection
From Experiments to Expression Data
\begin_inset CommandInset label
LatexCommand label
name "subsec:From-Experiments-to"

\end_inset


\end_layout

\begin_layout Standard
To go from an experiment accession identifier in the ArrayExpress database
 to the actual expression values of the arrays referenced in the curated
 data set, I planned to use the 
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
rpkg{ArrayExpress}
\end_layout

\end_inset

 package with its main function that should do exactly that: take an accession,
 and return an annotated 
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
code{data.frame}
\end_layout

\end_inset

 with probe IDs in rows and samples in columns - with the annotation containing
 the metadata of the experiment.
 This was not working for the majority of experiments however, so I rewrote
 parts of the package and gave the patches to the original maintainers (for
 detailed list of changes, see the BioConductor VCS diff between 1.28.1 and
 1.30.1).
 The update package has been downloaded by over 4,000 people since
\begin_inset Foot
status open

\begin_layout Plain Layout
\begin_inset CommandInset href
LatexCommand href
target "http://bioconductor.org/packages/stats/bioc/ArrayExpress/"

\end_inset


\end_layout

\end_inset

\SpecialChar endofsentence

\end_layout

\begin_layout Standard
\begin_inset Float table
wide false
sideways false
status open

\begin_layout Plain Layout
\begin_inset Caption Standard

\begin_layout Plain Layout
\begin_inset Argument 1
status collapsed

\begin_layout Plain Layout
Microarray platforms used in the curated experiments
\end_layout

\end_inset

Microarray platforms used in the curated experiments
\begin_inset CommandInset label
LatexCommand label
name "tab:ma-platforms"

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Plain Layout
\align center
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
centerline{
\end_layout

\end_inset


\begin_inset Tabular
<lyxtabular version="3" rows="18" columns="4">
<features tabularvalignment="middle">
<column alignment="center" valignment="top">
<column alignment="center" valignment="top">
<column alignment="center" valignment="top">
<column alignment="center" valignment="top">
<row>
<cell alignment="center" valignment="top" topline="true" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
ArrayExpress Platform ID
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" topline="true" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GEO Platform ID
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" topline="true" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Platform design package
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" topline="true" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Annotation package
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
A-AFFY-9
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GPL91
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
pd.hg.u95a
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
hgu95a.db
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
A-AFFY-10
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GPL92
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
pd.hg.u95b
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
hgu95b.db
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
A-AFFY-1
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GPL8300
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
pd.hg.u95av2
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
hgu95av2.db
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
A-AFFY-33
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GPL96
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
pd.hg.u133a
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
hgu133a.db
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
A-AFFY-34
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GPL97
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
pd.hg.u133b
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
hgu133b.db
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
A-AFFY-44
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GPL570
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
pd.hg.u133.plus.2
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
hgu133plus2.db
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
A-AFFY-37
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GPL571
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
pd.hg.u133a.2
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
hgu133a2.db
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
A-GEOD-13667
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GPL13667
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
pd.hg.u219
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
hgu219.db
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
A-AFFY-141
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GPL6244
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
pd.hugene.1.0.st.v1
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
hugene10sttranscriptcluster.db
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
A-GEOD-11532
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GPL11532
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
pd.hugene.1.1.st.v1
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
hugene11sttranscriptcluster.db
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
A-AFFY-141
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GPL6244
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
pd.hugene.2.0.st
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
hugene20sttranscriptcluster.db
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
A-GEOD-17692
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GPL17692
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
pd.hugene.2.1.st
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
hugene21sttranscriptcluster.db
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
A-AFFY-143
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GPL20188
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
pd.huex.1.0.st.v1
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
huex10sttranscriptcluster.db
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
A-GEOD-16209
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GPL16209
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
pd.huex.1.0.st.v2
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
huex10sttranscriptcluster.db
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
A-AFFY-76 
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GPL3921
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
pd.ht.hg.u133a
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
hthgu133a.db
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
A-GEOD-13158
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GPL13158
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
pd.ht.hg.u133.plus.pm
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
?
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
A-GEOD-17586
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GPL17586
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
pd.hta.2.0
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
hta20sttranscriptcluster.db
\end_layout

\end_inset
</cell>
</row>
</lyxtabular>

\end_inset


\begin_inset ERT
status open

\begin_layout Plain Layout

}
\end_layout

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Standard
With the R package patched, I was able to download the associated data with
 all the Affymetrix accessions.
 I fitted a probe-level model (PLM) for each accession, calculating the
 
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
code{NUSE}
\end_layout

\end_inset

 and 
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
code{RLE}
\end_layout

\end_inset

 quality control scores for each array.
 Arrays that had a 
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
code{NUSE}
\end_layout

\end_inset

 or 
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
code{RLE}
\end_layout

\end_inset

 over 0.1 I discarded as quality control failures.
 If less than two control and one perturbed array were remaining, I removed
 the whole experiment.
 If there were enough, I performed background correction, normalisation,
 and probe summarisation using the 
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
code{rma}
\end_layout

\end_inset

 function in the 
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
rpkg{oligo}
\end_layout

\end_inset

 
\begin_inset CommandInset citation
LatexCommand cite
key "Carvalho2010-xu"

\end_inset

 or 
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
rpkg{affy}
\end_layout

\end_inset

 
\begin_inset CommandInset citation
LatexCommand cite
key "Gautier2004-bx"

\end_inset

 package (depending on whether the object was a 
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
code{FeatureSet}
\end_layout

\end_inset

 or 
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
code{AffyBatch}
\end_layout

\end_inset

, respectively) using the corresponding platform design package.
 I then mapped the probe set identifiers to Human Genome Nomenclature Consortium
 (HGNC) symbols using the respective annotation packages (platform design
 and annotation package see table 
\begin_inset CommandInset ref
LatexCommand ref
reference "tab:ma-platforms"

\end_inset

).
 I discarded probe identifiers mapping to more than one HGNC symbol, and
 averaged multiple probe sets that belonged to the same HGNC symbol using
 the 
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
code{avereps}
\end_layout

\end_inset

 function in the 
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
rpkg{limma}
\end_layout

\end_inset

 package 
\begin_inset CommandInset citation
LatexCommand cite
key "Smyth2005-mw"

\end_inset

.
 After processing and quality control, a total of 568 experiments and 2867
 arrays remained, with a total of over 64 million single-gene measurements.
\end_layout

\begin_layout Section
A model for perturbation-response experiments
\end_layout

\begin_layout Subsection
Building a linear model from z-scores
\begin_inset CommandInset label
LatexCommand label
name "subsec:Transformation-of-Z-scores"

\end_inset


\begin_inset CommandInset label
LatexCommand label
name "subsec:Building-the-Model"

\end_inset


\end_layout

\begin_layout Standard
\begin_inset Float figure
wide false
sideways false
status open

\begin_layout Plain Layout
\align center
\begin_inset Graphics
	filename figures/pathway-structure.pdf
	lyxscale 50
	width 40text%

\end_inset


\end_layout

\begin_layout Plain Layout
\begin_inset Caption Standard

\begin_layout Plain Layout
\begin_inset Argument 1
status collapsed

\begin_layout Plain Layout
Structure of the perturbation-response model
\end_layout

\end_inset

Structure of the perturbation-response model.
 For the multiple linear regression, I set the coefficients or perturbed
 pathways to 1 if a pathway was perturbed, 0 otherwise.
 In addition, EGFR perturbation also had MAPK and PI3K coefficients set,
 and TNFa had NFkB set.
\begin_inset CommandInset label
LatexCommand label
name "fig:Modelled-pathway-crosstalk"

\end_inset


\end_layout

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Standard
With the curated experiments, one requirement was that there were at least
 two arrays available that represent the control condition.
 This way, I can use the distribution of the control condition of each gene
 symbol as the reference distribution, and calculate the number of standard
 deviations that the average perturbed sample lies above or beneath its
 mean:
\end_layout

\begin_layout Standard
\begin_inset Formula 
\[
z_{i}=\frac{\overline{x}_{i}-\mu_{i}}{\sigma_{i}}
\]

\end_inset


\end_layout

\begin_layout Standard
where 
\begin_inset Formula $i$
\end_inset

 is the index of the gene, 
\begin_inset Formula $z_{i}$
\end_inset

 is the obtained z-score, 
\begin_inset Formula $\bar{x}_{i}$
\end_inset

 is the mean perturbed expression level, 
\family roman
\series medium
\shape up
\size normal
\emph off
\bar no
\strikeout off
\uuline off
\uwave off
\noun off
\color none

\begin_inset Formula $\mu_{i}$
\end_inset

 is the mean expression level of the reference condition and 
\begin_inset Formula $\sigma_{i}$
\end_inset

 its standard deviation.
 In addition, I use a 
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
code{loess}
\end_layout

\end_inset

 model to smooth the relationship between a gene's expression level and
 its variance across samples as described in 
\begin_inset CommandInset citation
LatexCommand citep
key "Parikh2010-uj"

\end_inset

.

\family default
\series default
\shape default
\size default
\emph default
\bar default
\strikeout default
\uuline default
\uwave default
\noun default
\color inherit
 From the z-scores of all experiments and all pathways, I performed a multiple
 linear regression with the pathway as input and the z-scores as response
 variable for each gene separately:
\end_layout

\begin_layout Standard
\begin_inset Formula 
\[
Z_{g}\sim M\,...\,\forall g
\]

\end_inset


\end_layout

\begin_layout Standard
\begin_inset Float figure
wide false
sideways false
status open

\begin_layout Plain Layout
\align center
\begin_inset Graphics
	filename figures/sig_sign-1.pdf
	lyxscale 50
	width 80text%

\end_inset


\end_layout

\begin_layout Plain Layout
\align center
\begin_inset Graphics
	filename figures/sig_zscore-1.pdf
	lyxscale 50
	width 80text%

\end_inset


\end_layout

\begin_layout Plain Layout
\begin_inset Caption Standard

\begin_layout Plain Layout
\begin_inset Argument 1
status collapsed

\begin_layout Plain Layout
Distribution of the top 100 genes used in the model, as outcome for the
 multiple regression of all pathways
\end_layout

\end_inset

Distribution of the top 100 genes used in the model, as outcome for the
 multiple regression of all pathways.
 Top: Distribution of FDR-corrected p-values for signature genes (double
 log).
 Genes (horizonal axis) are ordered by significance.
 Dashed line at 5% FDR, dotted line at 
\begin_inset Formula $10^{-10}$
\end_inset

.
 Bottom: Distribution of z-scores of the top 100 significant genes (different
 order compared to a).
 Signature genes are comprised of both up- and downregulated genes for most
 of the pathways.
 In no pathway a single or a few z-scores are high enough to overshadow
 the rest of the signature, indicating that the model is numerically stable.
\begin_inset CommandInset label
LatexCommand label
name "fig:Distribution-of-significance"

\end_inset


\end_layout

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Standard
Where 
\begin_inset Formula $Z_{g}$
\end_inset

 is the z-score for a given gene 
\begin_inset Formula $g$
\end_inset

 across all input experiments (as a column vector of experiments).
 
\begin_inset Formula $M$
\end_inset

 is a coefficients matrix (rows are experiments, columns pathways) that
 has the coefficient 
\begin_inset Formula $1$
\end_inset

 if the the experiment had a pathway activated, 
\begin_inset Formula $-1$
\end_inset

 if inhibited, and 
\begin_inset Formula $0$
\end_inset

 otherwise.
 For instance, the Hypoxia pathway had experiments with low oxygen conditions
 set as 
\begin_inset Formula $1$
\end_inset

, HIF1A knockdown as 
\begin_inset Formula $-1$
\end_inset

, and all other experiments as 
\begin_inset Formula $0$
\end_inset

.
 The same is true for EGFR and EGF treatment vs.
 EGFR inhibitors respectively, with the additional coefficients of MAPK
 and PI3K pathways set to 
\begin_inset Formula $1$
\end_inset

 because of known pathway cross-talk.
 An overview of all modelled cross-talk is shown in figure 
\begin_inset CommandInset ref
LatexCommand ref
reference "fig:Modelled-pathway-crosstalk"

\end_inset

.
\end_layout

\begin_layout Standard
\begin_inset Float figure
wide false
sideways false
status open

\begin_layout Plain Layout
\align center
\begin_inset Graphics
	filename figures/sig_overlap-1.pdf
	lyxscale 50
	width 70text%

\end_inset


\end_layout

\begin_layout Plain Layout
\begin_inset Caption Standard

\begin_layout Plain Layout
\begin_inset Argument 1
status collapsed

\begin_layout Plain Layout
Overlap of signature genes for different pathways
\end_layout

\end_inset

Overlap of signature genes for different pathways.
 For the 100 genes I selected for each individual pathway, this shows how
 many of those signature genes are present in another pathway as well.
 The overlap is generally minimal, with the highest numbers between TNFa
 and NFkB (18 of 100) and EGFR and MAPK (9 of 100).
 As both of these pathway pairs have one component that is directly upstream
 of the other, this is to be expected.
 It also shows that the response genes are specific to their perturbation
 and not a common phenotype like stress response that happens with any perturbat
ion.
\end_layout

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Standard
From the result of the linear model, I selected the top 100 genes per pathway
 according to their p-value and took their estimate (the fitted z-scores)
 as coefficient.
 I set all other gene coefficients to 0, so this yielded a matrix with HGNC
 symbols in rows and pathways in columns, where each pathway had 100 non-zero
 gene coefficients (cf.
 figure 
\begin_inset CommandInset ref
LatexCommand ref
reference "fig:Workflow-of-obtaining"

\end_inset

).
\end_layout

\begin_layout Subsection
Computing pathway scores
\begin_inset CommandInset label
LatexCommand label
name "subsec:method:speed-scores"

\end_inset


\end_layout

\begin_layout Standard
For each pathway signature I obtain an 
\begin_inset Formula $N$
\end_inset

-dimensional vector in gene expression space 
\begin_inset Formula $Z_{i}$
\end_inset

.
 This vector defines not only a direction, but also a plane on the origin
 of a coordinate system whose normal it represents.
 The distance of each sample (
\begin_inset Formula $A$
\end_inset

) from that plane corresponds to the activation state of the pathway, calculated
 as the dot product between 
\begin_inset Formula $Z_{i}$
\end_inset

 and the gene expression of a given sample (or fold change).
 A schema of this is shown in figure 
\begin_inset CommandInset ref
LatexCommand ref
reference "fig:dot-product"

\end_inset

.
\end_layout

\begin_layout Standard
\begin_inset Float figure
wide false
sideways false
status open

\begin_layout Plain Layout
\align center
\begin_inset Graphics
	filename figures/dot_product.pdf
	width 50text%

\end_inset


\end_layout

\begin_layout Plain Layout
\begin_inset Caption Standard

\begin_layout Plain Layout
\begin_inset Argument 1
status collapsed

\begin_layout Plain Layout
2-dimensional schema of a distance calculation of a point from a plane by
 means of a dot product
\end_layout

\end_inset

2-dimensional schema of a distance calculation of a point from a plane by
 means of a dot product.
 The plane is defined by its normal vector, and the distance between it
 and the point marked 
\begin_inset Formula $A$
\end_inset

 is calculated by using the formula 
\begin_inset Formula $\overrightarrow{n}\cdot\vec{A}$
\end_inset

.
\begin_inset CommandInset label
LatexCommand label
name "fig:dot-product"

\end_inset


\end_layout

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Standard
While the above only explains how to calculate the score for one pathway
 in one sample, I have 11 pathways and 
\begin_inset Formula $M$
\end_inset

 samples.
 Each column in the matrix of perturbation-response genes (
\begin_inset Formula $Z$
\end_inset

 with 
\begin_inset Formula $N$
\end_inset

 genes in rows and 
\begin_inset Formula $M$
\end_inset

 samples in columns) corresponds to a plane in gene expression space (
\begin_inset Formula $Z_{i}$
\end_inset

 with 
\begin_inset Formula $N$
\end_inset

 genes, 
\begin_inset Formula $i\in M$
\end_inset

).
 For samples, I have a gene expression matrix 
\begin_inset Formula $E$
\end_inset

 with genes in columns (
\begin_inset Formula $N$
\end_inset

 dimensions) and samples in rows (
\begin_inset Formula $M$
\end_inset

 dimensions).
 I can now calculate all the dot products between 
\begin_inset Formula $Z_{i}$
\end_inset

 and 
\begin_inset Formula $E_{sample}$
\end_inset

 by performing a matrix multiplication to yield 
\begin_inset Formula $P$
\end_inset

, a matrix with all pathway scores (rows, indexed by 
\begin_inset Formula $i$
\end_inset

) in all samples (columns, 
\begin_inset Formula $M$
\end_inset

 dimensions):
\end_layout

\begin_layout Standard
\begin_inset Formula 
\[
P=E*Z
\]

\end_inset


\end_layout

\begin_layout Standard
This approach is vastly simpler and more computationally efficient than
 any other way of computing scores for other pathway methods that I compare
 in section 
\begin_inset CommandInset ref
LatexCommand ref
reference "subsec:Methods:pathway-scores"

\end_inset

.
 As I am more interested in the relative activation status between samples
 than the absolute values that are not particularly meaningful, I scaled
 each pathway or gene set score to have a mean of zero and standard deviation
 of one across all samples.
\end_layout

\begin_layout Subsection
Consensus gene signatures reveal pathway-response transcriptional modules
\begin_inset CommandInset label
LatexCommand label
name "subsec:Perturbation-Associations"

\end_inset


\end_layout

\begin_layout Standard
\begin_inset Float figure
wide false
sideways false
status open

\begin_layout Plain Layout
\align center
\begin_inset Graphics
	filename figures/global_structure-1.pdf
	width 100text%

\end_inset


\end_layout

\begin_layout Plain Layout
\begin_inset Caption Standard

\begin_layout Plain Layout
\begin_inset Argument 1
status collapsed

\begin_layout Plain Layout
T-SNE plots for separation of perturbation experiments
\end_layout

\end_inset

T-SNE plots for separation of perturbation experiments with different pathways
 in different colours.
 Fold changes of genes in individual perturbation experiments (10% FDR)
 do not cluster by pathway (left).
 Using a consensus signature of genes whose z-score is most consistently
 deregulated for each pathway instead, we can observe distinct clusters
 of perturbed pathways (right).
\begin_inset CommandInset label
LatexCommand label
name "fig:t-SNE-plots-of"

\end_inset


\end_layout

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Standard
Each experiment in my data set consisted of between 3 and 30 arrays, measuring
 between 8597 and 24,041 genes (72% over 15,000 genes).
 For extracting the individual signatures for each experiment, I calculated
 differential expression between the basal and perturbed condition and selected
 all fold changes that were significant at 10% FDR.
 If the pathway was inhibited, I took the negative fold changes.
 This yielded between 1 and 14,014 z-scores of significantly changing genes,
 reflecting the strength of the perturbation, experimental design and number
 of genes on the array.
 I assembled a matrix of significant fold changes by setting all non-significant
 or non-existent gene coefficients to 0, and use t-SNE 
\begin_inset CommandInset citation
LatexCommand citep
key "Van_der_Maaten2008-kt,Van_der_Maaten2013-io"

\end_inset

 for dimensionality reduction on that matrix.
\end_layout

\begin_layout Standard
Looking at the fold changes in each perturbation experiment, I do not see
 an obvious clustering in which pathway was perturbed (figure 
\begin_inset CommandInset ref
LatexCommand ref
reference "fig:t-SNE-plots-of"

\end_inset

, left).
 Distances between the fold changes of different experiments are about equal,
 with the slight exception of JAK-STAT and Hypoxia that are grouped to some
 extend, but the fold changes do not allow for a separation of pathways.
\end_layout

\begin_layout Standard
To compare this to my model, I calculated pathway scores from the unfiltered
 fold changes of my input experiments, or negative fold changes in the case
 of inhibitions.
 Applying the model building as described in section 
\begin_inset CommandInset ref
LatexCommand ref
reference "subsec:Transformation-of-Z-scores"

\end_inset

, I obtain an expression matrix with genes in rows and pathways in columns.
 As this is a linear model of the z-scores of those different pathways,
 I can obtain activation scores (my inferred pathway activity) by a matrix
 multiplication between the model matrix and gene expression values from
 samples, as long as the identifiers are in the same order.
 Using only the top 100 significant genes (figure 
\begin_inset CommandInset ref
LatexCommand ref
reference "fig:Distribution-of-significance"

\end_inset

), I can show a separation of all pathways in groups (and some weak perturbation
s overlapping in the centre).
 However, these clusters only tell us that across all scores, individual
 pathways produce patterns distinct from others.
 It does not tell us the obtained scores actually correspond to the perturbed
 pathway.
\end_layout

\begin_layout Standard
I calculate linear associations using the 
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
code{lm}
\end_layout

\end_inset

 function in R between a pathway coefficients matrix (experiments in rows
 and pathways in columns, with the value 
\begin_inset Formula $1$
\end_inset

 where a pathway was activated, 
\begin_inset Formula $-1$
\end_inset

 where a pathway was inhibited, and 
\begin_inset Formula $0$
\end_inset

 otherwise; here, no cross-talk was modelled explicitly) and the pathway
 scores obtained by using the different methods as described in sections
 
\begin_inset CommandInset ref
LatexCommand ref
reference "subsec:method:speed-scores"

\end_inset

 and 
\begin_inset CommandInset ref
LatexCommand ref
reference "subsec:Methods:pathway-scores"

\end_inset

.
 I then plot the result of the associations as a matrix (figure 
\begin_inset CommandInset ref
LatexCommand ref
reference "fig:sp2-exp-heatmap"

\end_inset

, left) where the perturbed pathway and the obtained pathway score are on
 the axes, and the colour (blue for positive and red for negative correlation)
 indicates the Wald statistic between them.
\end_layout

\begin_layout Standard
With the linear model I use for this purpose (implementation details in
 section 
\begin_inset CommandInset ref
LatexCommand ref
reference "subsec:Perturbation-Associations"

\end_inset

), I find that all pathway scores are strongly associated with the perturbation
 they were derived from (figure 
\begin_inset CommandInset ref
LatexCommand ref
reference "fig:sp2-exp-heatmap"

\end_inset

, left), and some for a perturbation with a known pathway cross-talk (e.g.
 EGFR activating MAPK or TNFa activating NFkB).
\end_layout

\begin_layout Standard
\begin_inset Float figure
wide false
sideways false
status open

\begin_layout Plain Layout
\align center
\begin_inset Graphics
	filename figures/4.2_recall_speed-matrix.pdf
	lyxscale 50
	width 100col%

\end_inset


\end_layout

\begin_layout Plain Layout
\begin_inset Caption Standard

\begin_layout Plain Layout
\begin_inset Argument 1
status collapsed

\begin_layout Plain Layout
Recovery of the perturbations using the consensus signature
\end_layout

\end_inset

Recovery of the perturbations across pathways (left) and for individual
 experiments (right) using the consensus signature.
 Left: Associations calculated between perturbed pathways and the scores
 obtained by the model of pathway-response genes (PRGs).
 Along the diagonal each pathway is strongly (
\begin_inset Formula $p<10^{-10}$
\end_inset

) associated with its own perturbation.
 Significant off-diagonal elements are sparse and only show a strong association
 between EGFR/MAPK and TNFa/NFkB and a weaker association (
\begin_inset Formula $p<10^{-5}$
\end_inset

) between EGFR/PI3K and MAPK/TNFa.
 Right: Heatmap of relative pathway scores in each perturbation experiment.
 523 experiments in columns, annotated with the perturbation effect (green
 for activation, orange for inhibition) and pathway perturbed (same order
 as b).
 Pathway scores in rows cluster between EGFR/MAPK and to a lesser extent
 PI3K, and TNFa/NFkB.
 Colour indicates activation or inhibition strength.
 Order of pathways: EGFR, H2O2, Hypoxia, JAK-STAT, MAPK, NFkB, PI3K, TGFb,
 TNFa, Trail, VEGF, and p53.
\begin_inset CommandInset label
LatexCommand label
name "fig:sp2-exp-heatmap"

\end_inset


\end_layout

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Standard
As a method for inspection of the pathway scores of the individual experiments,
 I plot a heatmap using the R package 
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
rpkg{pheatmap}
\end_layout

\end_inset

 with the pathways scores in rows, experiments in columns, and the colour
 indicates the relative (column-scaled) activation of each pathway (figure
 
\begin_inset CommandInset ref
LatexCommand ref
reference "fig:sp2-exp-heatmap"

\end_inset

, right).
 In order to make activations and inhibitions more comparable, I take the
 negative pathway score for each inhibition and annotate the columns separately
 indicating which pathway was perturbed, and which kind of perturbation
 it was.
 This way, I can show clusters of similar pathway activation patterns that
 should correspond to the pathways that were perturbed.
\end_layout

\begin_layout Standard
The above test showed us that the mean of assigned scores is significantly
 altered when a given pathway is perturbed, but it gives us only limited
 information about the heterogeneity in the individual experiments.
 To this end, I calculated the relative pathway activations for each individual
 experiment (details section 
\begin_inset CommandInset ref
LatexCommand ref
reference "subsec:Perturbation-Associations"

\end_inset

) and show the results in a heatmap ordered by perturbation (figure 
\begin_inset CommandInset ref
LatexCommand ref
reference "fig:sp2-exp-heatmap"

\end_inset

, right).
 For easier interpretation, I show all scores in the direction of activation
 by taking the negative scores of inhibitions (so red indicates a match,
 not necessarily an activation) and indicating whether the original experiment
 was an activation or inhibition separately.
 We can clearly see that the majority of pathway scores across experiments
 agrees with the pathway that was actually perturbed in the experiment.
\end_layout

\begin_layout Standard
Taken together, those two approaches imply that the perturbation-response
 signature is both correct on average, as well as in the majority of individual
 cases.
 For the remaining cases, I do not know if this is something my (admittedly
 very simple) model misses or the pathway was not sufficiently perturbed
 with the given parameters the experimentalists used (e.g.
 a low concentration of the perturbing agent, too little time for genes
 to change their expression significantly, or a general experimental error).
\end_layout

\begin_layout Section
Comparison to pathway mapping methods
\end_layout

\begin_layout Subsection
Transcriptional footprints are fundamentally different to pathway expression
\end_layout

\begin_layout Standard
As already indicated in my initial motivation (figure 
\begin_inset CommandInset ref
LatexCommand ref
reference "fig:Schema-of-different"

\end_inset

), commonly used pathway methods map the mRNA expression level of signalling
 molecules on the corresponding pathways to infer a pathway-level score.
\end_layout

\begin_layout Standard
\begin_inset Float figure
wide false
sideways false
status open

\begin_layout Plain Layout
\align center
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
centerline{
\end_layout

\end_inset


\begin_inset Graphics
	filename figures/3.4_venn.pdf
	lyxscale 50
	width 120col%

\end_inset


\begin_inset ERT
status open

\begin_layout Plain Layout

}
\end_layout

\end_inset


\end_layout

\begin_layout Plain Layout
\begin_inset Caption Standard

\begin_layout Plain Layout
\begin_inset Argument 1
status collapsed

\begin_layout Plain Layout
Difference in gene sets between Perturbation-response genes and Gene Ontology/Re
actome
\end_layout

\end_inset

Difference in gene sets between Perturbation-response genes and Gene Ontology/Re
actome.
 Perturbation-response genes are different to path- way members and gene
 annotations, with between 0 and 4 genes in common.
 However, pathway annotation is quite different from gene annotations here
 as well.
\begin_inset CommandInset label
LatexCommand label
name "fig:gene-VENN"

\end_inset


\end_layout

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Standard
But are those really different? Maybe the genes expressed upon pathway perturbat
ion are feedback regulators of the same pathway.
 In this case, pathway mapping could very well identify perturbations because
 those are already incorporated in the pathway structure.
\end_layout

\begin_layout Standard
However, I find that the overlap of my pathway-responsive genes and known
 Gene Ontology categories or Reactome pathways is either small or non-existent,
 as shown in figure 
\begin_inset CommandInset ref
LatexCommand ref
reference "fig:gene-VENN"

\end_inset


\end_layout

\begin_layout Standard
\begin_inset Float figure
wide false
sideways false
status open

\begin_layout Plain Layout
\align center
\begin_inset Graphics
	filename figures/3.4_footprints-go.pdf
	width 50col%

\end_inset


\end_layout

\begin_layout Plain Layout
\begin_inset Caption Standard

\begin_layout Plain Layout
\begin_inset Argument 1
status collapsed

\begin_layout Plain Layout
Functional annotations of perturbation-response genes
\end_layout

\end_inset

Functional annotations of perturbation-response genes
\begin_inset CommandInset label
LatexCommand label
name "fig:sig-GO-enrichment"

\end_inset


\end_layout

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Standard
Notwithstanding these differences, computing which unfiltered GO gene sets
 are over-represented in our signature genes may still give us additional
 insight into which lower-level processes (and not signalling pathways)
 are activated upon pathway stimulation.
 For this, I computed enrichment of Gene Ontology categories using a Fisher's
 exact test and all gene sets that had between 5 and 500 members.
\end_layout

\begin_layout Standard
What I find is largely expected, but it also goes to show that modulation
 of signalling pathways mainly triggers expression changes in biological
 processes related to the pathway and not the pathway members itself.
\end_layout

\begin_layout Standard
For instance (figure 
\begin_inset CommandInset ref
LatexCommand ref
reference "fig:sig-GO-enrichment"

\end_inset

), EGFR and MAPK drive, while p53-mediated DNA damage response abrogates
 the cell cycle and DNA replication (especially the G1/S checkpoint 
\begin_inset CommandInset citation
LatexCommand citep
key "Di_Leonardo1994-gg"

\end_inset

).
 In addition, MAPK and p53 have more specific opposing roles in components
 of the spindle pole or mRNA splicing (among others).
 PI3K stimulation also promotes G1/S transition, as well as regulation of
 ubiquitin.
 Hypoxia on the other hand inhibits the expression of G1/S genes and mitochondri
a-related genes (where oxidative phosphorylation happens 
\begin_inset CommandInset citation
LatexCommand citep
key "Schultz2001-nl"

\end_inset

).
 TNFa/NFkB show enrichment in the category of genes responsive to known
 pathway activator 
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
abbrv{LPS}
\end_layout

\end_inset

 
\begin_inset CommandInset citation
LatexCommand citep
key "P_A_Baeuerle1994-yu"

\end_inset

, and so does Trail 
\begin_inset CommandInset citation
LatexCommand citep
key "Halaas2000-yy"

\end_inset

.
\end_layout

\begin_layout Subsection
Computing pathway scores for other methods
\begin_inset CommandInset label
LatexCommand label
name "subsec:Methods:pathway-scores"

\end_inset


\end_layout

\begin_layout Subsubsection
Pathway and Gene Ontology scores
\end_layout

\begin_layout Standard
I matched my defined set of pathways to the publicly available pathway databases
 Reactome 
\begin_inset CommandInset citation
LatexCommand citep
key "Croft2011-po"

\end_inset

 and KEGG 
\begin_inset CommandInset citation
LatexCommand citep
key "Kanehisa2000-mp,Kanehisa2009-rr"

\end_inset

, and Gene Ontology (GO) 
\begin_inset CommandInset citation
LatexCommand citep
key "Ashburner2000-xl,Gene_Ontology_Consortium2004-sn"

\end_inset

 categories.
 In order to make them comparable, I selected the same set of pathways across
 different resources.
 I calculated pathway scores for these sets using GSVA as described in section
 
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
ref{subsec:GSVA}
\end_layout

\end_inset

.
\end_layout

\begin_layout Standard
The pathways I used are shown in table 
\begin_inset CommandInset ref
LatexCommand ref
reference "tab:Mapping-go"

\end_inset

 for Gene Ontology, table 
\begin_inset CommandInset ref
LatexCommand ref
reference "tab:Mapping-reactome"

\end_inset

 for Reactome (used in Reactome enrichment and Pathifier), and KEGG in table
 
\begin_inset CommandInset ref
LatexCommand ref
reference "tab:Mapping-spia"

\end_inset

 (used in Signaling Pathway Impact Analysis).
\end_layout

\begin_layout Standard
\begin_inset Float table
wide false
sideways false
status open

\begin_layout Plain Layout
\begin_inset Caption Standard

\begin_layout Plain Layout
\begin_inset Argument 1
status collapsed

\begin_layout Plain Layout
Mapping of pathways to Gene Ontology Categories
\end_layout

\end_inset

Mapping of pathways to Gene Ontology Categories
\begin_inset CommandInset label
LatexCommand label
name "tab:Mapping-go"

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Plain Layout
\align center
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
centerline{
\end_layout

\end_inset


\begin_inset Tabular
<lyxtabular version="3" rows="13" columns="3">
<features tabularvalignment="middle">
<column alignment="center" valignment="top">
<column alignment="center" valignment="top">
<column alignment="center" valignment="top">
<row>
<cell multirow="3" alignment="center" valignment="middle" topline="true" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Pathway
\end_layout

\end_inset
</cell>
<cell multicolumn="1" alignment="center" valignment="top" topline="true" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Gene Ontology
\end_layout

\end_inset
</cell>
<cell multicolumn="2" alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\end_layout

\end_inset
</cell>
</row>
<row>
<cell multirow="4" alignment="center" valignment="top" rightline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
ID
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Name
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
EGFR
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GO:0007259
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
ERBB signaling pathway
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Hypoxia
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GO:0071456
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
cellular response to hypoxia
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
JAK-STAT
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GO:0007259
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
JAK-STAT signal transduction
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
MAPK
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GO:0000165
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
MAPK cascade
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
NFkB
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GO:0038061
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
NIK/NF-kappaB signaling
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
p53
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GO:0030330
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
DNA damage response, signal transduction by p53 class mediator
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
PI3K
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GO:0014065
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
phosphatidylinositol 3-kinase signaling
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
TNFa
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GO:0033209
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
tumor necrosis factor-mediated signaling pathway
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
TGFb
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GO:0007179
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
transforming growth factor beta receptor signaling pathway
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Trail
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GO:0036462
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
TRAIL-activated apoptotic signaling pathway
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
VEGF
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
GO:0038084
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
vascular endothelial growth factor signaling pathway
\end_layout

\end_inset
</cell>
</row>
</lyxtabular>

\end_inset


\begin_inset ERT
status open

\begin_layout Plain Layout

}
\end_layout

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Subsubsection
SPIA scores
\end_layout

\begin_layout Standard
Signaling Pathway Impact Analysis (SPIA) 
\begin_inset CommandInset citation
LatexCommand citep
key "Tarca2008-ey"

\end_inset

 is a method that utilizes the directionality and signs in a KEGG pathway
 graph to determine if in a given pathway structure the available species
 are more or less able to transduce a signal.
 As the species considered for a pathway are usually mRNAs of genes, this
 method still infers signalling activity by proxy of gene expression.
 In order to do this, SPIA scores require the comparison with a normal condition
 in order to compute both their scores and their significance.
\end_layout

\begin_layout Standard
I used the 
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
rpkg{SPIA}
\end_layout

\end_inset

 BioConductor package 
\begin_inset CommandInset citation
LatexCommand citep
key "Tarca_undated-ol"

\end_inset

 in my analyses that implements an updated version of the 2008 algorithm.
 I calculated my pathway scores either for each cell line compared to the
 rest of a given tissue (for the GDSC and drug response data) or compared
 to the tissue-matched normals (for the TCGA data used in driver and survival
 associations).
\end_layout

\begin_layout Standard
\begin_inset Float table
wide false
sideways false
status open

\begin_layout Plain Layout
\align center
\begin_inset Caption Standard

\begin_layout Plain Layout
\begin_inset Argument 1
status collapsed

\begin_layout Plain Layout
Mapping of pathways to SPIA (KEGG pathways)
\end_layout

\end_inset

Mapping of pathways to SPIA (KEGG pathways)
\begin_inset CommandInset label
LatexCommand label
name "tab:Mapping-spia"

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Plain Layout
\align center
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
centerline{
\end_layout

\end_inset


\begin_inset Tabular
<lyxtabular version="3" rows="13" columns="3">
<features tabularvalignment="middle">
<column alignment="center" valignment="top">
<column alignment="center" valignment="top">
<column alignment="center" valignment="top">
<row>
<cell multirow="3" alignment="center" valignment="middle" topline="true" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Pathway
\end_layout

\end_inset
</cell>
<cell multicolumn="1" alignment="center" valignment="top" topline="true" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
SPIA
\end_layout

\end_inset
</cell>
<cell multicolumn="2" alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\end_layout

\end_inset
</cell>
</row>
<row>
<cell multirow="4" alignment="center" valignment="top" rightline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
ID
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Name
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
EGFR
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
04012
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
ErbB signaling pathway
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Hypoxia
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
-
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
-
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
JAK-STAT
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
04630
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Jak-STAT signaling pathway
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
MAPK
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
04010
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
MAPK signaling pathway
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
NFkB
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
04064
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
NF-kappa B signaling pathway
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
p53
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
-
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
-
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
PI3K
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
04150
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
mTOR signaling pathway
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
TNFa
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
-
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
-
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
TGFb
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
04350
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
TGF-beta signaling pathway
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Trail
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
04210
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Apoptosis
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
VEGF
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
04370
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
VEGF signaling pathway
\end_layout

\end_inset
</cell>
</row>
</lyxtabular>

\end_inset


\begin_inset ERT
status open

\begin_layout Plain Layout

}
\end_layout

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Subsubsection
Pathifier scores
\end_layout

\begin_layout Standard
As with SPIA, Pathifier 
\begin_inset CommandInset citation
LatexCommand citep
key "Drier2013-vn"

\end_inset

 requires the comparison with a normal condition in order to compute its
 scores.
 The difference is that it infers pathway structure from gene expression
 data itself instead of relying on prior knowledge.
\end_layout

\begin_layout Standard
I used the 
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
rpkg{Pathifier}
\end_layout

\end_inset

 BioConductor package 
\begin_inset CommandInset citation
LatexCommand citep
key "Drier2013-vn"

\end_inset

 in my analyses.
 I calculated pathway scores either for each cell line compared to the rest
 of a given tissue (for the GDSC and drug response data) or compared to
 the tissue-matched normals (for the TCGA data used in driver and survival
 associations).
\end_layout

\begin_layout Standard
\begin_inset Float table
wide false
sideways false
status open

\begin_layout Plain Layout
\align center
\begin_inset Caption Standard

\begin_layout Plain Layout
\begin_inset Argument 1
status collapsed

\begin_layout Plain Layout
Mapping of pathways to Pathifier (Reactome pathways)
\end_layout

\end_inset

Mapping of pathways to Pathifier (Reactome pathways)
\begin_inset CommandInset label
LatexCommand label
name "tab:Mapping-reactome"

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Plain Layout
\align center
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
centerline{
\end_layout

\end_inset


\begin_inset Tabular
<lyxtabular version="3" rows="19" columns="2">
<features tabularvalignment="middle">
<column alignment="center" valignment="top">
<column alignment="center" valignment="top">
<row>
<cell multirow="3" alignment="center" valignment="top" topline="true" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Pathway
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" topline="true" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Name
\end_layout

\end_inset
</cell>
</row>
<row>
<cell multirow="3" alignment="center" valignment="middle" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
EGFR
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Signaling by EGFR
\end_layout

\end_inset
</cell>
</row>
<row>
<cell multirow="4" alignment="center" valignment="top" rightline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Signaling by EGFR in Cancer
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Hypoxia
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Cellular response to hypoxia
\end_layout

\end_inset
</cell>
</row>
<row>
<cell multirow="3" alignment="center" valignment="middle" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
JAK-STAT
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Signaling by Interleukins
\end_layout

\end_inset
</cell>
</row>
<row>
<cell multirow="4" alignment="center" valignment="top" rightline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Interferon Signaling
\end_layout

\end_inset
</cell>
</row>
<row>
<cell multirow="4" alignment="center" valignment="top" rightline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Signalling to STAT3
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
MAPK
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Signalling to ERKs
\end_layout

\end_inset
</cell>
</row>
<row>
<cell multirow="3" alignment="center" valignment="middle" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
NFkB
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
TAK1 activates NFkB:w: by phosphorylation and activation of IKKs complex
\end_layout

\end_inset
</cell>
</row>
<row>
<cell multirow="4" alignment="center" valignment="top" rightline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
RIP-mediated NFkB activation via ZBP1
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
p53
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Transcriptional Regulation by TP53
\end_layout

\end_inset
</cell>
</row>
<row>
<cell multirow="3" alignment="center" valignment="middle" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
PI3K
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
PI3K Cascade
\end_layout

\end_inset
</cell>
</row>
<row>
<cell multirow="4" alignment="center" valignment="top" rightline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Constitutive Signaling by Aberrant PI3K in Cancer
\end_layout

\end_inset
</cell>
</row>
<row>
<cell multirow="4" alignment="center" valignment="top" rightline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
PI3K/AKT Signaling in Cancer
\end_layout

\end_inset
</cell>
</row>
<row>
<cell multirow="4" alignment="center" valignment="top" rightline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
PI3K/AKT activation
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
TNFa
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
TNF signaling
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
TGFb
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Signaling by TGF-beta Receptor Complex
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Trail
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
TRAIL signaling
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
VEGF
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Signaling by VEGF
\end_layout

\end_inset
</cell>
</row>
</lyxtabular>

\end_inset


\begin_inset ERT
status open

\begin_layout Plain Layout

}
\end_layout

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Subsubsection
PARADIGM scores
\end_layout

\begin_layout Standard
I downloaded the PARADIGM software from the public software repository
\begin_inset Foot
status collapsed

\begin_layout Plain Layout
\begin_inset CommandInset href
LatexCommand href
target "https://github.com/sbenz/Paradigm"

\end_inset


\end_layout

\end_inset

 and a model of the cell signalling network published in 
\begin_inset CommandInset citation
LatexCommand citep
key "The_Cancer_Genome_Atlas_Research_Network2013-bi"

\end_inset

 from the corresponding TCGA publication
\begin_inset Foot
status collapsed

\begin_layout Plain Layout
\begin_inset CommandInset href
LatexCommand href
target "https://tcga-data.nci.nih.gov/docs/publications/coadread_2012/"

\end_inset


\end_layout

\end_inset

.
 I used my 
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
code{voom}
\end_layout

\end_inset

-transformed RNA-seq gene expression data that I normalized using ranks
 to assign equally spaced values between 0 and 1 for each sample within
 a given tissue, as recommended in the manual.
 I then ran PARADIGM inference using the same options as in the above publicatio
n for each sample separately.
 I used nodes in the network representing pathway activity to our set of
 pathways to obtain pathway scores that are comparable to the other methods,
 averaging scores where there were more than one for a given sample and
 node.
\end_layout

\begin_layout Standard
\begin_inset Float table
wide false
sideways false
status open

\begin_layout Plain Layout
\align center
\begin_inset Caption Standard

\begin_layout Plain Layout
\begin_inset Argument 1
status collapsed

\begin_layout Plain Layout
Mapping of pathways to PARADIGM nodes
\end_layout

\end_inset

Mapping of pathways to PARADIGM nodes
\begin_inset CommandInset label
LatexCommand label
name "tab:Mapping-paradigm"

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Plain Layout
\align center
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
centerline{
\end_layout

\end_inset


\begin_inset Tabular
<lyxtabular version="3" rows="13" columns="2">
<features tabularvalignment="middle">
<column alignment="center" valignment="top">
<column alignment="center" valignment="top">
<row>
<cell multirow="3" alignment="center" valignment="middle" topline="true" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Pathway
\end_layout

\end_inset
</cell>
<cell multirow="3" alignment="center" valignment="middle" topline="true" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
PARADIGM
\end_layout

\end_inset
</cell>
</row>
<row>
<cell multirow="4" alignment="center" valignment="top" rightline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\end_layout

\end_inset
</cell>
<cell multirow="4" alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
EGFR
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
epidermal growth factor receptor activity (abstract)
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Hypoxia
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
response to hypoxia (abstract)
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
JAK-STAT
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
STAT-1-3-5-active
\end_layout

\end_inset
</cell>
</row>
<row>
<cell multirow="3" alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
MAPK
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
MEK-1-2-active
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
NFkB
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
NFkB Complex (complex)
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
p53
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
response to DNA damage stimulus (abstract)
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
PI3K
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
PIK3CA
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
TNFa
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
tumor necrosis factor receptor activity (abstract)
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
TGFb
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
SMAD1-5-8-active
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Trail
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
induction of apoptosis (abstract)
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
VEGF
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
platelet-derived growth factor receptor activity (abstract)
\end_layout

\end_inset
</cell>
</row>
</lyxtabular>

\end_inset


\begin_inset ERT
status open

\begin_layout Plain Layout

}
\end_layout

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Subsection
Comparison within perturbation experiments
\end_layout

\begin_layout Standard
\begin_inset Float figure
wide false
sideways false
status open

\begin_layout Plain Layout
\align center
\begin_inset Graphics
	filename figures/4.2_recall_reactome.pdf
	lyxscale 50
	width 100col%

\end_inset


\end_layout

\begin_layout Plain Layout
\align center
\begin_inset Graphics
	filename figures/4.2_recall_go.pdf
	lyxscale 50
	width 100col%

\end_inset


\end_layout

\begin_layout Plain Layout
\begin_inset Caption Standard

\begin_layout Plain Layout
\begin_inset Argument 1
status collapsed

\begin_layout Plain Layout
Perturbation recall for pathway member GSEA
\end_layout

\end_inset

Comparison to pathway member GSVA.
 Significant associations (marked with 
\begin_inset Formula $*$
\end_inset

 for 
\begin_inset Formula $p<10^{-5}$
\end_inset

 and *** for 
\begin_inset Formula $p<10^{-10}$
\end_inset

) between a pathway perturbation and a higher (blue) or lower (red) pathway
 score are shown on the left, pathway scores for individual experiments
 on the right (order of pathways: EGFR, H2O2, Hypoxia, JAK-STAT, MAPK, NFkB,
 PI3K, TGFb, TNFa, Trail, VEGF, p53)
\begin_inset CommandInset label
LatexCommand label
name "fig:Comparison-to-pathway-perturb"

\end_inset


\end_layout

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Standard
My first investigation is to which extent pathway expression is correlated
 with known perturbations.
 They would be if the perturbation causes feedback cycles where stimulation
 (or inhibition) of a pathway will lead to changes in the expression of
 some of its own components, such as inhibitors in the case of negative
 feedback.
\end_layout

\begin_layout Standard
But is this enough of a change to determine pathway activity from the gene
 expression of its components? If so, it would enable the expression to
 be used as an actionable biomarker for modulating the pathway's activity,
 e.g.
 by means of treatment using a kinase inhibitor.
 If not, we can still use it as a measure of pathway expression, but not
 make statements about its activity or whether adding a drug would change
 its state.
\end_layout

\begin_layout Standard
For methods based on Gene Set Enrichment Analysis (Reactome, BioCarta, Gene
 Ontology), the associations they provide between a perturbed pathway and
 a significant change in score (figure 
\begin_inset CommandInset ref
LatexCommand ref
reference "fig:Comparison-to-pathway-perturb"

\end_inset

) are very much different from the pathway scores obtained from the consensus
 of the response itself (figure 
\begin_inset CommandInset ref
LatexCommand ref
reference "fig:sp2-exp-heatmap"

\end_inset

).
 Reactome shows the strongest associations for the perturbation and pathway
 score for Hypoxia and JAK-STAT (followed by NFkB, MAPK, and JAK-STAT pathway
 expression upon NFkB perturbation).
 Gene Ontology shows strong self-associations for Hypoxia and NFkB, and
 NFkB expression changes upon TNFa stimulation.
\end_layout

\begin_layout Standard
\begin_inset Float figure
wide false
sideways false
status open

\begin_layout Plain Layout
\align center
\begin_inset Graphics
	filename figures/4.2_recall_spia.pdf
	lyxscale 50
	width 100col%

\end_inset


\end_layout

\begin_layout Plain Layout
\align center
\begin_inset Graphics
	filename figures/4.2_recall_pathifier.pdf
	lyxscale 50
	width 100col%

\end_inset


\end_layout

\begin_layout Plain Layout
\begin_inset Caption Standard

\begin_layout Plain Layout
\begin_inset Argument 1
status collapsed

\begin_layout Plain Layout
Perturbation recall for other pathway methods
\end_layout

\end_inset

Comparison to other pathway methods, legend as in figure 
\begin_inset CommandInset ref
LatexCommand ref
reference "fig:Comparison-to-pathway-perturb"

\end_inset


\begin_inset CommandInset label
LatexCommand label
name "fig:Comparison-to-other"

\end_inset


\end_layout

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Standard
These results provide a further confirmation that pathway expressed as defined
 as a consensus score of pathway members is fundamentally different to pathway
 activity and can not be used as a measure for such.
 All the categories that provide strong associations are explicitly curated
 to contain the pathway response, as opposed to the members.
 This is true for a 
\begin_inset Quotes eld
\end_inset

Response to Hypoxia
\begin_inset Quotes erd
\end_inset

 for Reactome and Gene Ontology (cf.
 tables 
\begin_inset CommandInset ref
LatexCommand ref
reference "tab:Mapping-reactome"

\end_inset

 and 
\begin_inset CommandInset ref
LatexCommand ref
reference "tab:Mapping-go"

\end_inset

), while the BioCarta pathway that does not provide an association focussed
 more on the pathway itself.
 A similar pattern can be observed for TNFa/NFkB and the 
\begin_inset Quotes eld
\end_inset

Response to LPS
\begin_inset Quotes erd
\end_inset

 category (also tables 
\begin_inset CommandInset ref
LatexCommand ref
reference "tab:Mapping-reactome"

\end_inset

 and 
\begin_inset CommandInset ref
LatexCommand ref
reference "tab:Mapping-go"

\end_inset

).
\end_layout

\begin_layout Standard
SPIA (figure 
\begin_inset CommandInset ref
LatexCommand ref
reference "fig:Comparison-to-other"

\end_inset

, top) seems to assign more extreme relative scores to a couple of pathways
 (MAPK, EGFR, NFkB, Trail) no matter which pathway was perturbed.
 It does not show a clear unique link between a pathway stimulation and
 its impact on scores in the same pathway.
 Pathifier (figure 
\begin_inset CommandInset ref
LatexCommand ref
reference "fig:Comparison-to-pathway-perturb"

\end_inset

, bottom) fails to derive scores for the majority of perturbation experiments
 (their method tries to construct principal curves from control-experiments
 that need at least three arrays in that condition) and for the remaining
 does not provide any strong associations (with the strongest being the
 up-regulation of the hypoxic response upon JAK-STAT stimulation, otherwise
 all 
\begin_inset Formula $p>10^{-5}$
\end_inset

).
\end_layout

\begin_layout Subsection
Comparison across perturbation experiments
\end_layout

\begin_layout Standard
The previous section focussed on pathway activation in relative terms (whether,
 given a pathway perturbation, the score assigned to any one pathway is
 higher or lower compared to other pathways).
 I am now interested in how well pathway methods are able to assign activity
 scores across different experiments.
 I use as input data the fold changes (difference in 
\begin_inset Formula $log$
\end_inset

 space, or negative difference if inhibition) of the curated perturbation
 experiments, and see how well the pathway scores derived from those are
 ordered for each pathway across experiments.
 This is meant as a comparison of how well the pathway scores obtained by
 different methods correspond to perturbations, and not to assign significance
 of the perturbation-response signature model.
\begin_inset Foot
status open

\begin_layout Plain Layout
Because then I would need an independent set of experiments.
 This is not required as I assessed the significance of the genes in the
 model analytically, with results shown in figure 
\begin_inset CommandInset ref
LatexCommand ref
reference "fig:Distribution-of-significance"

\end_inset

.
 The comparison here serves to show that my model corresponds better to
 perturbations.
\end_layout

\end_inset


\end_layout

\begin_layout Standard
\begin_inset Float figure
wide false
sideways false
status open

\begin_layout Plain Layout
\align center
\begin_inset Graphics
	filename figures/perturb-roc.pdf
	width 100col%

\end_inset


\end_layout

\begin_layout Plain Layout
\begin_inset Caption Standard

\begin_layout Plain Layout
\begin_inset Argument 1
status collapsed

\begin_layout Plain Layout
Perturbation recall on input experiments as a comparison across methods
 for each pathway
\end_layout

\end_inset

Perturbation recall on input experiments as a comparison across methods
 for each pathway.
 ROC curves for different methods ranking perturbation experiments by their
 pathway score.
 Pathway-response genes (PRGs) show better performance for all pathways
 except JAK-STAT and NFkB, where other methods are equal.
 Gene Ontology and Reactome scores are obtained by Gene Set Variation Analysis
 (GSVA).
 Pathifier using Reactome gene sets.
 Performance is indicated with the area under each curve, values indicated
 in table 
\begin_inset CommandInset ref
LatexCommand ref
reference "tab:ROC_AUC"

\end_inset

.
 Lines for methods are only drawn if there were at least five experiments
 where a given pathway was perturbed and the method could derive scores.
\begin_inset CommandInset label
LatexCommand label
name "fig:ROC"

\end_inset


\end_layout

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Standard
\begin_inset Float table
wide false
sideways false
status open

\begin_layout Plain Layout
\begin_inset Caption Standard

\begin_layout Plain Layout
\begin_inset Argument 1
status collapsed

\begin_layout Plain Layout
Area under the ROC curve for experiment recall
\end_layout

\end_inset

Area under the ROC curve (AUC) for methods and pathways in figure 
\begin_inset CommandInset ref
LatexCommand ref
reference "fig:ROC"

\end_inset

.
 Best performance in bold.
\begin_inset CommandInset label
LatexCommand label
name "tab:ROC_AUC"

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Plain Layout
\align center
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
centerline{
\end_layout

\end_inset


\begin_inset Tabular
<lyxtabular version="3" rows="13" columns="6">
<features tabularvalignment="middle">
<column alignment="center" valignment="top">
<column alignment="center" valignment="top">
<column alignment="center" valignment="top">
<column alignment="center" valignment="top">
<column alignment="center" valignment="top">
<column alignment="center" valignment="top">
<row>
<cell multirow="3" alignment="center" valignment="middle" topline="true" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Pathway
\end_layout

\end_inset
</cell>
<cell multicolumn="1" alignment="center" valignment="top" topline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Method
\end_layout

\end_inset
</cell>
<cell multicolumn="2" alignment="center" valignment="top" topline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\end_layout

\end_inset
</cell>
<cell multicolumn="2" alignment="center" valignment="top" topline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\end_layout

\end_inset
</cell>
<cell multicolumn="2" alignment="center" valignment="top" topline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\end_layout

\end_inset
</cell>
<cell multicolumn="2" alignment="center" valignment="top" topline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\end_layout

\end_inset
</cell>
</row>
<row>
<cell multirow="4" alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" topline="true" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Perturbation-response
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" topline="true" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Gene Ontology
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" topline="true" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Reactome
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" topline="true" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
SPIA
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" topline="true" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Pathifier
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
EGFR
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\series bold
0.84
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.38
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.50
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.64
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.50
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Hypoxia
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\series bold
0.95
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.86
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.86
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
-
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.71
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
JAK-STAT
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\series bold
0.80
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.76
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.50
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.43
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.76
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
MAPK
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\series bold
0.83
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.59
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.46
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.29
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.48
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
NFkB
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.77
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.56
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.75
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\series bold
0.79
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.60
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
PI3K
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\series bold
0.81
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.26
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.47
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.35
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.46
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
TGFb
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\series bold
0.94
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.68
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.75
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.15
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
-
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
TNFa
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\series bold
0.87
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.70
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.53
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
-
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.63
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
Trail
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\series bold
0.91
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.42
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.56
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.52
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.39
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
VEGF
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\series bold
0.76
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.58
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.52
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.52
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.52
\end_layout

\end_inset
</cell>
</row>
<row>
<cell alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
p53
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout

\series bold
0.86
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.32
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.67
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
-
\end_layout

\end_inset
</cell>
<cell alignment="center" valignment="top" bottomline="true" usebox="none">
\begin_inset Text

\begin_layout Plain Layout
0.48
\end_layout

\end_inset
</cell>
</row>
</lyxtabular>

\end_inset


\begin_inset ERT
status open

\begin_layout Plain Layout

}
\end_layout

\end_inset


\end_layout

\end_inset


\end_layout

\begin_layout Standard
The standard non-parametric (
\begin_inset ERT
status open

\begin_layout Plain Layout


\backslash
latin{i.e.}
\end_layout

\end_inset

, only based on order rather than value) of quantifying this is the area
 under Receiver-Operator (ROC) curves, the results of which is shown in
 figure 
\begin_inset CommandInset ref
LatexCommand ref
reference "fig:ROC"

\end_inset

 (AUCs in table 
\begin_inset CommandInset ref
LatexCommand ref
reference "tab:ROC_AUC"

\end_inset

).
 For all pathways except NFkB and JAK-STAT (where multiple methods are tied),
 the consensus gene signature I derived is also better able to detect pathway
 activations across experiments.
 VEGF is not well recovered by any method, potentially due to the relatedness
 with EGFR/MAPK and the low number of experiments.
 Interestingly, SPIA in 4 out of 11 cases systematically assigns pathway
 scores in the wrong direction of the experimental perturbations (this may
 be due to increased expression of negative feedback regulators that SPIA
 picks up due to the underlying directed KEGG graph).
\end_layout

\begin_layout Section
Discussion
\end_layout

\begin_layout Subsection
Need for an improved database and model
\end_layout

\begin_layout Standard
As I have outlined already in the discussion of chapter 2, the original
 SPEED implementation suffered from a multitude of arbitrary cutoffs (z-score,
 overall expression, highest expressed fraction of genes, whether the signature
 genes are allowed to overlap between pathways), highly correlated gene
 sets (that could be fixed by optimising those cutoffs), discarding most
 of its information (not taking into account down-regulated genes in general,
 modestly but consistently upregulated genes, etc.), and potentially weak
 input experiments (mostly processed data without any knowledge of how this
 was done, calculating z-scores for only one control condition, and never
 thoroughly assessing the quality of the model).
\end_layout

\begin_layout Standard
Also the results that I obtained in terms of drug associations were significant
 but not stellar.
 This, combined with the fact that the original database was curated in
 2010 where there were fewer perturbation experiments available, is an indicatio
n that building a new database could result in a much improved model.
\end_layout

\begin_layout Subsection
Value of curated perturbation experiments
\end_layout

\begin_layout Standard
The average entry in the ArrayExpress database comes with a fair level of
 curation.
 Newer entries are often linked to ontology terms in the Experimental Factor
 Ontology 
\begin_inset CommandInset citation
LatexCommand citep
key "Malone2010-mz"

\end_inset

 or others.
 Linking those to pathways, however, is non-trivial because the available
 information is not accessible via an API.
 This is only possible using the Gene Expression Atlas 
\begin_inset CommandInset citation
LatexCommand citep
key "Parkinson2007-bf,Parkinson2009-ej"

\end_inset

, but it also requires a much higher level of curation than the experiments
 that are just deposited in the database and hence the number of experiments
 that made it into the Atlas is much smaller.
 In order to interrogate cellular systems (as those provided by the GDSC
 and the TCGA in this study), I needed a high number of perturbation experiments
 that are not available in the Atlas yet.
 This required a focussed curation of those pathways.
\end_layout

\begin_layout Standard
The value of this approach, combined with putting it into a machine readable
 format that includes metadata (as opposed to the original SPEED database
 that came either as a collection of un-annotated text files or SQLite database)
, allows for easy reuse in other projects and extension by adding additional
 experiments or pathways.
\end_layout

\begin_layout Subsection
Importance of distinguishing between pathway expression and activity
\end_layout

\begin_layout Standard
Seeing how my model compares to other pathway methods that map mRNA expression
 to signalling molecules in one way or another underlines the importance
 of distinguishing between pathway expression and activity and, by extension,
 that the expression of pathway members should not be used to make inferences
 about activity.
 This is irrespective of using the pathway as a simple gene set or a directed
 graph.
 Pathway expression alone does not tell us much about the involved biology
 (a more expressed pathway likely only has an impact on the cell if it is
 more active as well.
\end_layout

\begin_layout Standard
However, this is a jump in reasoning that we can not make for the reasons
 outlined above.
 Also, pathway expression is not actionable by itself, because there is
 no straightforward way to change the expression of a pathway instead of
 its activity (as does a drug, for instance).
\end_layout

\begin_layout Standard
It can of course be argued that there are feedback loops where the stimulation
 of a pathway triggers changes in expression in its components (as I find
 with JAK-STAT and Hypoxia), either in the same (positive feedback) or the
 opposite (negative feedback) direction.
\end_layout

\begin_layout Standard
This way of thinking makes sense only for positive feedback on the same
 pathway: if it is negative feedback we would see an incorrect decrease
 of expression or a increase of associated inhibitors (I see this kind of
 correlation using SPIA and how it incorrectly orders experiments in figure
 
\begin_inset CommandInset ref
LatexCommand ref
reference "fig:ROC"

\end_inset

), or if it is on another pathway we would assign significance to the expression
 change of this pathway although this is merely a downstream consequence
 that did not cause the phenotype we observe at all.
\end_layout

\begin_layout Standard
I can not claim that my model will always find causal aberrations.
 But I do argue that it is more likely for it to find them compared to other
 pathway methods, because the way it infers pathway activity from gene expressio
n is closer to the actual activity by definition.
 If this is true, I would expect it not only to be able to recover known
 perturbation experiments better (figures 
\begin_inset CommandInset ref
LatexCommand ref
reference "fig:Comparison-to-pathway-perturb"

\end_inset

 and 
\begin_inset CommandInset ref
LatexCommand ref
reference "fig:Comparison-to-other"

\end_inset

) but also provide more insight into which pathways driver activate mutations
 and influence drug sensitivity due to oncogene addiction.
 Now that I have a model that I know corresponds to pathway perturbations
 in a wide range of conditions I can actually put those statements to the
 test.
\end_layout

\begin_layout Standard
\begin_inset CommandInset bibtex
LatexCommand bibtex
bibfiles "references"
options "plain"

\end_inset


\end_layout

\end_body
\end_document
